Skip to main content

2023 SSO Annual Meeting Main banner

Tweets by 2023 SSO Annual Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Speaker

Browse by Speaker

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

N
Naffouje, Samer

Cleveland Clinic Foundation
97: Long-term Oncologic Outcomes Following Pathologic Complete Response (pCR) for Esophageal Cancer
Location:Ballroom A
Samer Naffouje
Nagathihalli, Nagaraj

University of Miami, Miller School of Medicine, Department of Surgery
P32: p38 MAPK inhibition reprograms the inflammatory stroma to overcome the immunosuppressive tumor microenvironment in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Nagaraj Nagathihalli
Nagorney, David

Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
David Nagorney
Naoum, George

Northwestern University Memorial Hospital
9: Breast cancer-related lymphedema and its relationship to major landmark trials in surgical oncology and radiation oncology
Location:Veterans Memorial Auditorium
George Naoum
Narod, Steven

Women's College Research Institute
6: Population-based survival outcomes of pure vs mixed invasive Lobular Breast Carcinoma in Ontario, Canada
Location:Veterans Memorial Auditorium
Steven Narod
Nash, Amanda

Duke University School of Medicine
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Amanda Nash
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
Amanda Nash
Nash, Garrett

Memorial Sloan Kettering Cancer Center
CON: HIPEC should NOT Indicated
Location:Ballroom B
Garrett Nash
P20: Microsatellite Instability (MSI): The Transition from Favorable to Unfavorable Outcomes with Lymph Node Metastases
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Garrett Nash
Rebuttal and Q&A
Location:Ballroom B
Garrett Nash
Nathan, Hari

University of Michigan
86: Identifying Characteristics of High-Performing Hospital Networks for Major Cancer Surgery
Location:Ballroom B
Hari Nathan
89: Variation in Postoperative Outcomes Across CMS Hospital Star Ratings for complex Cancer Surgery
Location:Ballroom B
Hari Nathan
Delivering Value in a Large Integrated Health System: Large Claims Data and Care Across the Network
Location:Ballroom A
Hari Nathan
Health Services Research Grants
Location:Room 304
Hari Nathan
P72: Association Of Hospital Network Affiliation with Surgical Outcomes and Spending For Complex Cancer: A longitudinal study of hospital mergers and acquisitions from 2010 to 2018
Location:SSO HUB: Rare/Metastatic Cancers Zone
Hari Nathan
Nathanson, Katherine

University of Pennsylvania, Medical Genetics
P25: What are the clinical implications of SDHA pathogenic variants?
Location:SSO HUB: Breast & Endocrine Zone
Katherine Nathanson
Naveed, Abdullah

VUMC
23: Single-cell RNA Sequencing Reveals Distinct Populations of Tumor Associated Macrophages in Colorectal Metastasis.
Location:Ballroom C
Abdullah Naveed
Navin, Patrick

Radiology
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Patrick Navin
Nelson, Jonas

Memorial Sloan Kettering Cancer Center
19: Sexual Well-being in Patients with Breast Cancer Surgery: Trends, Associated Factors, and Interventions.
Location:Veterans Memorial Auditorium
Jonas Nelson
P11: Satisfaction and well-being after contralateral prophylactic mastectomy among BRCA mutation carriers and non-carriers: a longitudinal analysis of BREAST-Q domains
Location:SSO HUB: Breast & Endocrine Zone
Jonas Nelson
Nelson, William

Allegheny Health Network
69: Peritoneal fluid cytokine analysis reveals targets for regional immunotherapy in carcinomatosis
Location:Ballroom B
William Nelson
Nessim, Carolyn

The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Carolyn Nessim
Neoadjuvant Chemotherapy for Soft Tissue Sarcomas: A Patient-Centric Approach
Location:Ballroom A
Carolyn Nessim
Neuman, Heather

University of Wisconsin School of Medicine and Public Health
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Heather Neuman
Neuwirth, Madalyn

Memorial Sloan Kettering Cancer Center
93: Effectiveness of Sentinel Lymph Node Mapping in Gastric Cancer
Location:Ballroom A
Madalyn Neuwirth
Newhams, Kirsten

Allegheny Health Network
69: Peritoneal fluid cytokine analysis reveals targets for regional immunotherapy in carcinomatosis
Location:Ballroom B
Kirsten Newhams
Newhook, Timothy

MD Anderson Cancer Center
36: KRAS-G12V and TP53 But Not KRAS-G12V Mutation Alone Is Associated with Worse Survival in Patients with Resected Colorectal Liver Metastasis
Location:Veterans Memorial Auditorium
Timothy Newhook
P39: Effect of Surgical Approach on Early Return to Intended Oncologic Therapy After Resection for Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Timothy Newhook
Updates in the Role of Multimodality Therapy for Colorectal Liver Metastases
Location:Ballroom B
Timothy Newhook
Newman, Lisa

Weill Cornell Medicines
American Cancer Society/SSO Diversity, Equity and Inclusion Lecture: Oncologic Anthropology: Unique Opportunities for Surgeons to Address Global Breast Cancer Disparities
Location:Veterans Memorial Auditorium
Lisa Newman
P8: Breast Cancer Among Asian Women in New York City: Disparities in Presentation and the Need for Disaggregated Data
Location:SSO HUB: Breast & Endocrine Zone
Lisa Newman
Questions and Discussion
Location:Ballroom C
Lisa Newman
Research in Global Surgical Oncology
Location:Ballroom C
Lisa Newman
Ngo, Fallon

UTSW
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Fallon Ngo
Nguyen, Alan

Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Alan Nguyen
Niemann, Britney

West Virginia University
104: Neoadjuvant Imatinib Permits Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor
Location:Veterans Memorial Auditorium
Britney Niemann
Nieroda, Carol

Mercy Medical Center
24: Sufficient Regional Lymph Node Examination for Staging High-Grade Appendix Cancer
Location:Ballroom C
Carol Nieroda
Nieweg, Omgo

Melanoma Institute Australia
59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials
Location:Veterans Memorial Auditorium
Omgo Nieweg
Nikahd, Melica

The Ohio State University Wexner Medical Center- Department of Biomedical Informatics
P59: Comparing complete compartmental resection with tumor only resection of retroperitoneal soft tissue sarcoma using the win ratio
Location:SSO HUB: Melanoma & Sarcoma Zone
Melica Nikahd
Nikiforchin, Andrei

The Institute for Cancer Care, Mercy Medical Center
24: Sufficient Regional Lymph Node Examination for Staging High-Grade Appendix Cancer
Location:Ballroom C
Andrei Nikiforchin
Nishioka, Yujiro

MD Anderson Cancer Center
36: KRAS-G12V and TP53 But Not KRAS-G12V Mutation Alone Is Associated with Worse Survival in Patients with Resected Colorectal Liver Metastasis
Location:Veterans Memorial Auditorium
Yujiro Nishioka
Nissen, Nicholas

Cedars-Sinai Medical Center - Los Angeles, CA
32: Impact of Primary Tumor Resection on Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Location:Ballroom A
Nicholas Nissen
Niu, Jiaxin

Banner MD Anderson Cancer Center
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Jiaxin Niu
Nix, Robert

UTSW
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Robert Nix
Nizri, Eran

Tel-Aviv Sourasky Medical Center
90: Obesity and Gastric Cancer Aggressiveness – a New Link
Location:Veterans Memorial Auditorium
Eran Nizri
P81: Neoadjuvant Chemotherapy for Gastric Cancer in the Elderly: Are We Accomplishing Our Treatment Goals or Should we Consider an Upfront Surgery Approach
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Eran Nizri
Norton, Jeffrey

Stanford Unoversity
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Jeffrey Norton
Nosrati, Fatemeh

Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Fatemeh Nosrati
Notware, Laura

Duke University Medical Center
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Laura Notware
Nuliyalu, Usha

University of Michigan
86: Identifying Characteristics of High-Performing Hospital Networks for Major Cancer Surgery
Location:Ballroom B
Usha Nuliyalu
89: Variation in Postoperative Outcomes Across CMS Hospital Star Ratings for complex Cancer Surgery
Location:Ballroom B
Usha Nuliyalu
P72: Association Of Hospital Network Affiliation with Surgical Outcomes and Spending For Complex Cancer: A longitudinal study of hospital mergers and acquisitions from 2010 to 2018
Location:SSO HUB: Rare/Metastatic Cancers Zone
Usha Nuliyalu
Núñez-Rocha, Ricardo

School of Medicine, Universidad de los Andes
102: Robotic-assisted minimally invasive radical total gastrectomy with intracorporeal side-to-side esophagojejunostomy
Location:Veterans Memorial Auditorium
Ricardo Núñez-Rocha
Nussbaum, Daniel

Duke University Medical Center
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Daniel Nussbaum
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Daniel Nussbaum
P79: Impact of Tumor Size and Management on Survival in Gastric GIST
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Daniel Nussbaum